A new study found the median cost of clinical trials in 2015 and 2016 to be $19 million, with a wide variation in costs. This study counters the assumption that elaborate and expensive clinical trials are the reason for the high costs of developing a new drug. Critics, however, argue that the study should not be misinterpreted as an estimate of drug development costs, as it has important limitations.